TAC has also been associated with other actions in vitro, such as promoting the expression of transforming growth factor-beta 1 (TGF-β1), which could underly the nephrotoxicity and pulmonary fibrosis associated with this drug [229]. Here, TGFB1 is linked to pulmonary fibrosis.